Cargando…
Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection
Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Perip...
Autores principales: | Jalali, Amirhossein, Kitching, Michael, Martin, Kenneth, Richardson, Ciaran, Murphy, Thomas Brendan, FitzGerald, Stephen Peter, Watson, Ronald William, Perry, Antoinette Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844261/ https://www.ncbi.nlm.nih.gov/pubmed/33510263 http://dx.doi.org/10.1038/s41598-021-81965-3 |
Ejemplares similares
-
A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort
por: Jalali, Amirhossein, et al.
Publicado: (2020) -
Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy
por: Moghaddam, Shirin, et al.
Publicado: (2021) -
Endoplasmic Reticulum Stress-Regulated Chaperones as a Serum Biomarker Panel for Parkinson’s Disease
por: Mnich, Katarzyna, et al.
Publicado: (2022) -
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation
por: Varnai, Reka, et al.
Publicado: (2019) -
Acute-phase serum amyloid A production by rheumatoid arthritis
synovial tissue
por: O'Hara, Rosemary, et al.
Publicado: (2000)